Mazzariello Gina: insider trades.
Mazzariello Gina reported 5 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($848K), across 1 company.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 4
- Companies
- 1
- Name as filed
- Mazzariello Gina
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Amylyx Pharmaceuticals, Inc. (AMLX) | Officer · Chief Legal Officer | 5 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-10 | Amylyx Pharmaceuticals, Inc. | S | 9,525 | $32.46 | 190,849 | Form 4 |
| 2026-09-10 | Amylyx Pharmaceuticals, Inc. | S | 11 | $33.34 | 190,838 | Form 4 |
| 2026-08-18 | Amylyx Pharmaceuticals, Inc. | A | 21,284 | $0 | 200,374 | Form 4 |
| 2026-07-10 | Amylyx Pharmaceuticals, Inc. | S | 15,000 | $17.61 | 179,090 | Form 4 |
| 2026-07-09 | Amylyx Pharmaceuticals, Inc. | S | 15,000 | $18.32 | 194,090 | Form 4 |
Questions
What stock did Mazzariello Gina buy or sell?
Mazzariello Gina reported 5 non-derivative transactions on 3 SEC ownership filings in Q3 2026: 0 open-market purchases and 4 sales ($848K), across 1 company.
Is Mazzariello Gina the same person as other filers with this name?
This page covers SEC CIK 1913765 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/mazzariello-gina-1913765.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.